1. Home
  2. MTN vs MIRM Comparison

MTN vs MIRM Comparison

Compare MTN & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTN
  • MIRM
  • Stock Information
  • Founded
  • MTN 1997
  • MIRM 2018
  • Country
  • MTN United States
  • MIRM United States
  • Employees
  • MTN N/A
  • MIRM N/A
  • Industry
  • MTN Services-Misc. Amusement & Recreation
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTN Consumer Discretionary
  • MIRM Health Care
  • Exchange
  • MTN Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • MTN 5.2B
  • MIRM 1.9B
  • IPO Year
  • MTN 1997
  • MIRM 2019
  • Fundamental
  • Price
  • MTN $144.50
  • MIRM $45.52
  • Analyst Decision
  • MTN Hold
  • MIRM Strong Buy
  • Analyst Count
  • MTN 10
  • MIRM 11
  • Target Price
  • MTN $190.00
  • MIRM $58.55
  • AVG Volume (30 Days)
  • MTN 585.3K
  • MIRM 412.6K
  • Earning Date
  • MTN 06-05-2025
  • MIRM 05-07-2025
  • Dividend Yield
  • MTN 6.19%
  • MIRM N/A
  • EPS Growth
  • MTN 10.73
  • MIRM N/A
  • EPS
  • MTN 6.89
  • MIRM N/A
  • Revenue
  • MTN $2,946,168,000.00
  • MIRM $379,251,000.00
  • Revenue This Year
  • MTN $4.64
  • MIRM $29.51
  • Revenue Next Year
  • MTN $4.21
  • MIRM $20.27
  • P/E Ratio
  • MTN $20.81
  • MIRM N/A
  • Revenue Growth
  • MTN 3.57
  • MIRM 69.31
  • 52 Week Low
  • MTN $129.85
  • MIRM $23.83
  • 52 Week High
  • MTN $206.38
  • MIRM $54.23
  • Technical
  • Relative Strength Index (RSI)
  • MTN 51.68
  • MIRM 63.46
  • Support Level
  • MTN $136.91
  • MIRM $40.00
  • Resistance Level
  • MTN $145.09
  • MIRM $47.43
  • Average True Range (ATR)
  • MTN 3.72
  • MIRM 2.00
  • MACD
  • MTN 1.26
  • MIRM 0.67
  • Stochastic Oscillator
  • MTN 94.90
  • MIRM 88.68

About MTN Vail Resorts Inc.

Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: